GS-9256

DB12876InvestigationalSmall molecule

GS-9256 has been used in trials studying the treatment of HCV Infection and Chronic Hepatitis C Infection.

Chemical structure of GS-9256
Formula / weight
C46H56ClF2N6O8PS · 957.47 g/mol (avg)
Code names
GS-9256

Resolves to

Compound
UNII8V42Y78HRUCAS1001094-46-7ChEMBLCHEMBL1956820PubChem24823649
Structure
InChIKeyRFGUWOCFYCYEDM-ZOMNBDOOSA-NSMILESCOC1=C(Cl)C2=NC(=CC(O[C@@H]3C[C@@H]4N(C3)C(=O)[C@H](CCCCCCC[C@@H]3C[C@]3(NC4=O)P(O)(=O)CC3=C(F)C=CC=C3F)NC(=O)OC3CCCC3)=C2C=C1)C1=CSC(NC(C)C)=N1
Targets
P03366gag-pol

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with GS-9256, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In